Pfizer centers to boost economy
Drug giant Pfizer will contribute a total of 1.6 billion euros to the Greek economy in the decade up to 2030, a study by the Foundation for Economic and Industrial Research (IOBE) has shown.
The activity of the US pharmaceutical giant in the local economy will directly and indirectly create 2,600 jobs in Athens and Thessaloniki, according to the report, titled “The Contribution of Pfizer in the Greek Economy,” presented this week at the 32nd Greek Annual Economic Summit, organized by the American-Hellenic Chamber of Commerce.
The study has taken into account the direct impact the company will have on Greece’s gross domestic product, its indirect influence on the supply chain connected with the company’s activity, and the effects on consumption on the part of those receiving their income from Pfizer and suppliers associated with its activity.
The IOBE study explained that Pfizer’s contribution to Greek GDP has almost doubled with the addition of the Center for Digital Innovation and of the Global Center for Business Operations and Services, both of which are based in Thessaloniki.
